Visualitzant - Articles científics per títol

Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design

Tabernero Caturla, Josep; Prager, Gerald W; Leger, Catherine; Fakih, Marwan; Taieb, Julien; Ciardiello, Fortunato (Future Medicine, 2021-06)

Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study

Van Cutsem, Eric; Danielewicz, I.; Saunders, M. P.; Pfeiffer, P.; Argilés Martinez, Guillem; Borg, Christophe (Elsevier, 2020-09)

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study

Tabernero Caturla, Josep; Shitara, Kohei; Zaanan, Aziz; Doi, Toshihiko; Lorenzen, S.; Van Cutsem, Eric; Alsina Maqueda, Maria (Elsevier, 2021-08)

Trigger‐Associated Clinical Implications and Outcomes in Takotsubo Syndrome: Results From the Multicenter GEIST Registry

Pätz, Toni; Santoro, Francesco; Cetera, Rosa; Ragnatela, Ilaria; El-Battrawy, Ibrahim; Mezger, Matthias; Andrés Villarreal, Mireia; Uribarri, Aitor (Wiley, 2023-07-18)

TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC

Levy, Benjamin; Cappuzzo, Federico; Yoneshima, Yasuto; Reck, Martin; Yang, James Chih-Hsin; FELIP, ENRIQUETA (Future Medicine, 2023-07)

TRPV4 Channels Promote Pathological, but Not Physiological, Cardiac Remodeling through the Activation of Calcineurin/NFAT and TRPC6

Yañez-Bisbe, Laia; Moya, Mar; Inserte, Javier; Tajes, M.; Ferreira González, Ignacio; Rodriguez-Sinovas, Antonio; Ruiz Meana, Marisol; miro casas, elisabet; Rivas-Gándara, Nuria; Benito, Begoña (MDPI, 2024-01-26)

TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumors

Nagasaka, Misako; Ohe, Yuichiro; Choi, Chang-Min; Yang, Nong; FELIP, ENRIQUETA; Zhou, Caicun; Liu, Geoffrey (Future Medicine, 2023-01)

TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance

Garcia Mayea, Yoelsis; Mir Perez, Cristina; Carballo Perich, Laia; Castellví Vives, Josep; Temprana Salvador, Jordi; Lorente Guerrero, Juan; Benavente Norza, Sergio; Lleonart Pajarin, Matilde (MDPI, 2020-11-05)

Tuberculosis contact tracing, Angola

Gil Olivas, Eva; Aixut, Sandra; Moreno, Milagros; Zacarias, Adriano; Nindia, Arlette; Sánchez Montalvá, Adrián; Aznar, María Luisa; Molina Romero, Israel; Martínez-Campreciós, Joan; Espinosa-Pereiro, Juan (World Health Organization, 2024-03-01)

TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex

Kingswood, John Christopher; Belousova, Elena; Perkovic Benedik, Mirjana; Carter, Tom; Cottin, Vincent; Macaya Ruíz, Alfons; Budde, Klemens (Frontiers Media, 2021-03-23)

TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients

Kingswood, John Christopher; d’Augères, Guillaume B.; Belousova, Elena; Ferreira, José C.; Carter, Tom; Castellana, Ramon; Macaya Ruíz, Alfons (BMC, 2017-01-05)

Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial

Lin, Nancy; Murthy, Rashmi; Abramson, Vandana; Anders, Carey; Bachelot, Thomas; Bedard, Philippe; Oliveira, Mafalda (American Medical Association, 2023-02)

Tumor analysis of MMR genes in Lynch-like syndrome: Challenges associated with results interpretation

Rofes, Paula; Duenas Cid, Nuria; del Valle, Jesús; Navarro, Matilde; Balmaña, Judith; Ramon y Cajal, Teresa (Wiley, 2024-04-01)

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

Casarrubios García, Marta; Garcia‑Campelo, Rosario; Martínez Marti, Alexandre; Insa, Amelia; Provencio, Mariano; Nadal, Ernest; Lázaro, Martín (BMJ, 2022-09)

Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment

Vergote, Ignace; Hirsch, Fred R.; Hagemann, Carsten; Miller, David; Macarulla, Teresa (MDPI, 2023-01-19)

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study

Gkika, Eleni; Grosu, Anca; Macarulla Mercade, Teresa; Brunner, Thomas B.; Schultheiß, Michael; Cubillo, Antonio (MDPI, 2022-03-18)

Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer

Taraborrelli, Lucia; Şenbabaoğlu, Yasin; Wang, Lifen; Lim, Junghyun; Blake, Kerrigan; Kljavin, Noelyn; Argilés Martinez, Guillem (Springer Nature, 2023-09-23)

Tweet me: conferencing in the era of COVID-19 and 280 characters

Stevens, Kate I.; Melilli, Edoardo; Diniz, Hugo; Gillis, Keith; Guerrot, Dominique; Montero, Nuria; Soler Romeo, Maria Jose (Oxford University Press, 2021-10)

Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry

Beck, Michael; Ramaswami, Uma; Hernberg‑Ståhl, Elizabeth; Hughes, Derralynn; Kampmann, Christoph; Mehta, Atul; Pintos Morell, Guillem (BMC, 2022-06-20)

Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency

Carreño Gago, Lidia; Juárez-Flores, DL; Grau, Josep Maria; Ramon Pasías, Javier Francisco; Lozano, Ester; Vila Julià, Ferran; Martí Seves, Ramón; Garrabou, Gloria; García Arumí, Elena (MDPI, 2021-08)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant HVH - Articles científics per títol

Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design

Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study

Trigger‐Associated Clinical Implications and Outcomes in Takotsubo Syndrome: Results From the Multicenter GEIST Registry

TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC

TRPV4 Channels Promote Pathological, but Not Physiological, Cardiac Remodeling through the Activation of Calcineurin/NFAT and TRPC6

TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumors

TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance

Tuberculosis contact tracing, Angola

TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex

TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients

Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial

Tumor analysis of MMR genes in Lynch-like syndrome: Challenges associated with results interpretation

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study

Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer

Tweet me: conferencing in the era of COVID-19 and 280 characters

Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry

Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant HVH - Articles científics per títol

Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design ﻿

Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study ﻿

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study ﻿

Trigger‐Associated Clinical Implications and Outcomes in Takotsubo Syndrome: Results From the Multicenter GEIST Registry ﻿

TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC ﻿

TRPV4 Channels Promote Pathological, but Not Physiological, Cardiac Remodeling through the Activation of Calcineurin/NFAT and TRPC6 ﻿

TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumors ﻿

TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance ﻿

Tuberculosis contact tracing, Angola ﻿

TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex ﻿

TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients ﻿

Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial ﻿

Tumor analysis of MMR genes in Lynch-like syndrome: Challenges associated with results interpretation ﻿

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy ﻿

Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment ﻿

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study ﻿

Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer ﻿

Tweet me: conferencing in the era of COVID-19 and 280 characters ﻿

Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry ﻿

Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design

Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study

Trigger‐Associated Clinical Implications and Outcomes in Takotsubo Syndrome: Results From the Multicenter GEIST Registry

TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC

TRPV4 Channels Promote Pathological, but Not Physiological, Cardiac Remodeling through the Activation of Calcineurin/NFAT and TRPC6

TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumors

TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance

Tuberculosis contact tracing, Angola

TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex

TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients

Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial

Tumor analysis of MMR genes in Lynch-like syndrome: Challenges associated with results interpretation

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study

Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer

Tweet me: conferencing in the era of COVID-19 and 280 characters

Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry

Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency